PR-Section 8 and 9

CIRCADIN

Neurim Pharmaceuticals (1991) Ltd.

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

PTO Form 1963 (Rev 5/2006)
OMB No. 0651-0055 (Exp 07/31/2018)

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


The table below presents the data as entered.

Input Field
Entered
REGISTRATION NUMBER 2790571
REGISTRATION DATE 12/09/2003
SERIAL NUMBER 76435551
MARK SECTION
MARK CIRCADIN
ATTORNEY SECTION (no change)
NAME Lawrence E. Abelman
FIRM NAME ABELMAN, FRAYNE & SCHWAB
STREET 666 THIRD AVENUE
CITY NEW YORK
STATE New York
POSTAL CODE 10017-5621
COUNTRY United States
DOCKET/REFERENCE NUMBER 868356
ATTORNEY SECTION (proposed)
NAME Lawrence E. Abelman
FIRM NAME ABELMAN, FRAYNE & SCHWAB
STREET 666 THIRD AVENUE
CITY NEW YORK
STATE New York
POSTAL CODE 10017-5621
COUNTRY United States
DOCKET/REFERENCE NUMBER 868356
OTHER APPOINTED ATTORNEY Julie B. Seyler, Marie-Anne Mastrovito, Frank Terranella
CORRESPONDENCE SECTION (no change)
NAME Lawrence E. Abelman
FIRM NAME ABELMAN, FRAYNE & SCHWAB
STREET 666 THIRD AVENUE
CITY NEW YORK
STATE New York
POSTAL CODE 10017-5621
COUNTRY United States
DOCKET/REFERENCE NUMBER 868356
DOMESTIC REPRESENTATIVE SECTION (new)
NAME Lawrence E. Abelman
STREET 666 THIRD AVENUE
CITY NEW YORK
STATE New York
POSTAL CODE 10017-5621
COUNTRY United States
DOCKET/REFERENCE NUMBER 868356
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
GOODS OR SERVICES Pharmaceutical preparation for the treatment of sleeping problems
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-216759226-195134735_._CIRCADIN.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT16\IMAGEOUT16\764\355\76435551\xml1\S890002.JPG
SPECIMEN DESCRIPTION Packaging
OWNER SECTION (current)
NAME Neurim Pharmaceuticals (1991) Ltd.
STREET 8 Hanechoshet Street
CITY Tel Aviv
ZIP/POSTAL CODE 69710
COUNTRY Israel
LEGAL ENTITY SECTION (current)
TYPE corporation
LEGAL ENTITY SECTION (proposed)
TYPE corporation
STATE/COUNTRY OF INCORPORATION Israel
PAYMENT SECTION
NUMBER OF CLASSES 1
NUMBER OF CLASSES PAID 1
SUBTOTAL AMOUNT 500
TOTAL FEE PAID 500
SIGNATURE SECTION
       ORIGINAL PDF FILE hw_216759226-195134735_._NEURIM__PA_.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT16\IMAGEOUT16\764\355\76435551\xml1\S890003.JPG
SIGNATORY'S NAME Moshe Laudon
SIGNATORY'S POSITION Director
PAYMENT METHOD DA
FILING INFORMATION
SUBMIT DATE Mon Nov 25 19:57:21 EST 2013
TEAS STAMP USPTO/S08N09-XXX.XX.XX.XX
-20131125195721485072-279
0571-500b0ada494787654d2e
5db66e3d55b9e996a691b95d3
b80b8cee58f959733f426-DA-
10427-2013112519513473533
6



PTO Form 1963 (Rev 5/2006)
OMB No. 0651-0055 (Exp 07/31/2018)


Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


To the Commissioner for Trademarks:

REGISTRATION NUMBER: 2790571
REGISTRATION DATE: 12/09/2003

MARK: CIRCADIN

The owner, Neurim Pharmaceuticals (1991) Ltd., a corporation of Israel, having an address of
      8 Hanechoshet Street
      Tel Aviv, 69710
      Israel
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: Pharmaceutical preparation for the treatment of sleeping problems ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) Packaging.

Original PDF file:
SPN0-216759226-195134735_._CIRCADIN.pdf
Converted PDF file(s) (1 page)
Specimen File1
The registrant's current Attorney Information: Lawrence E. Abelman of  ABELMAN, FRAYNE & SCHWAB
      666 THIRD AVENUE
      NEW YORK, New York (NY) 10017-5621
      United States
The docket/reference number is 868356.

The registrant's proposed Attorney Information: Lawrence E. Abelman of  ABELMAN, FRAYNE & SCHWAB
      666 THIRD AVENUE
      NEW YORK, New York (NY) 10017-5621
      United States
The docket/reference number is 868356.
The Other Appointed Attorney(s): Julie B. Seyler, Marie-Anne Mastrovito, Frank Terranella.

The registrant hereby appoints Lawrence E. Abelman, 666 THIRD AVENUE, NEW YORK, New York (NY) United States (USX) 10017-5621 as registrant's representative upon whom notice or process in the proceedings affecting the mark may be served.

A fee payment in the amount of $500 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.

Declaration



Original PDF file:
hw_216759226-195134735_._NEURIM__PA_.pdf
Converted PDF file(s) (1 page)
Signature File1
Signatory's Name: Moshe Laudon
Signatory's Position: Director

Mailing Address (current):
   ABELMAN, FRAYNE & SCHWAB
   666 THIRD AVENUE
   NEW YORK, New York 10017-5621

Mailing Address (proposed):
   ABELMAN, FRAYNE & SCHWAB
   666 THIRD AVENUE
   NEW YORK, New York 10017-5621

Serial Number: 76435551
Internet Transmission Date: Mon Nov 25 19:57:21 EST 2013
TEAS Stamp: USPTO/S08N09-XXX.XX.XX.XX-20131125195721
485072-2790571-500b0ada494787654d2e5db66
e3d55b9e996a691b95d3b80b8cee58f959733f42
6-DA-10427-20131125195134735336

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed